ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
advertisementadvertisement
International Immunopharmacology
Volume 7, Issue 10, October 2007, Pages 1286-1291
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (827 K)

  E-mail Article   
  Add to my Quick Links   
Bookmark and share in 2collab (opens in new window)
Request permission to reuse this article
  Cited By in Scopus (0)
 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.intimp.2007.05.006    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2007 Elsevier B.V. All rights reserved.

Anti-arthritic effect of ginsenoside Rb1 on collagen induced arthritis in mice

Hyun Ah Kima, Corresponding Author Contact Information, E-mail The Corresponding Author, Suho Kima, Sun Hwa Changb, Hea Jun Hwangb and Young-nim Choic

aDepartment of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea bOscotec Inc., Cheonan, Republic of Korea cDepartment of Oromaxillofacial Infection & Immunity, School of Dentistry and Dental Research Institute, Seoul National University, Seoul, Republic of Korea

Received 8 January 2007; 
revised 12 May 2007; 
accepted 14 May 2007. 
Available online 26 June 2007.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

Background

The development of orally bioavailable, inexpensive inhibitors of tumor necrosis factor (TNF)-α is desirable for the treatment of rheumatoid arthritis (RA).

Objective

To show the efficacy of ginsenoside Rb1 (G-Rb1), a ginseng extract, on the inhibition of TNF-α upregulation and on the inhibition of collagen induced arthritis (CIA).

Methods

Peripheral blood mononuclear cells (PBMC), chondrocytes and fibroblast-like synoviocytes (FLS) were stimulated with interferon(IFN)-γ, lipopolysaccharide (LPS) or interleukin-1 in the presence or absence of G-Rb1. The concentrations of (TNF)-α in the culture supernatants were determined by ELISA. CIA was induced in DBA/1J mice and G-Rb1 was prophylactically administered from day 20 until day 39 following immunization. Histopathologic changes were scored, and the expression of TNF-α was evaluated by immunohistochemistry.

Result

G-Rb1 significantly inhibited TNF-α upregulation in PBMCs, FLS and chondrocytes induced by IFN-γ, LPS or IL-1. Administration of G-Rb1 resulted in a significant amelioration of the clinical arthritis score in the CIA mice. Histology revealed that G-Rb1 reduced cell infiltration and cartilage destruction in the arthritic joint, which was accompanied by a significant decrease in TNF-α expression.

Conclusion

The utilization of G-Rb1 is a feasible approach to the treatment of RA or other diseases characterized by upregulation of TNF-α.

Keywords: Rheumatoid arthritis; Ginsenoside; Tumor necrosis factor(TNF)-alpha; Chondrocyte

Article Outline

1. Introduction
2. Materials and methods
2.1. Isolation and purification of G-Rb1
2.2. Stimulation of RA chondrocytes and fibroblast-like synoviocytes(FLS)
2.3. Stimulation of human PBMC
2.4. Elisa
2.5. Effect of G-Rb1 on collagen induced arthritis
2.6. Immunohistochemistry for TNF-α detection
2.7. Statistical analysis
3. Results
3.1. Amelioration of the clinical and histological score in collagen-induced arthritis by treatment with G-Rb1
4. Discussion
Acknowledgements
References




 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.